Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients.
about
Management of anaplastic thyroid cancerThe surgical management of thyroid cancer.Age as a prognostic factor in anaplastic thyroid cancer.A potential role for immunotherapy in thyroid cancer by enhancing NY-ESO-1 cancer antigen expressionChemotherapy for anaplastic thyroid cancer using docetaxel and cisplatin: report of eight casesTreatment and prognosis of anaplastic thyroid carcinoma: experience from a single institution in China.Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinomaComplete remission of anaplastic thyroid carcinoma after concomitant treatment with docetaxel and radiotherapyCoexpression of EpCAM, CD44 variant isoforms and claudin-7 in anaplastic thyroid carcinomaCharacterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.Concept and design of a nationwide prospective feasibility/efficacy/safety study of weekly paclitaxel for patients with pathologically confirmed anaplastic thyroid cancer (ATCCJ-PTX-P2).The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy.Treatment and Prognosis of Anaplastic Thyroid Carcinoma: A Clinical Study of 50 Cases.Anaplastic Thyroid Carcinoma, Version 2.2015.The PLK1 inhibitor GSK461364A is effective in poorly differentiated and anaplastic thyroid carcinoma cells, independent of the nature of their driver mutationsAggressive Disease Course of Papillary Thyroid Carcinoma with Focal Undifferentiated Component: A Case Report.Two cases of cervical hemorrhage with upper airway obstruction: a life-threatening condition.Interleukin-11 promotes epithelial-mesenchymal transition in anaplastic thyroid carcinoma cells through PI3K/Akt/GSK3β signaling pathway activation.Surgical management of appendicular skeletal metastases in thyroid carcinoma.Aggressive surgical resection of anaplastic thyroid carcinoma may provide long-term survival in selected patients.Aggressive variants of follicular cell derived thyroid carcinoma; the so called 'real thyroid carcinomas'.Anaplastic thyroid carcinoma: a 25-year single-institution experience.Treatment of patients with anaplastic thyroid cancer during the last 20 years: whether any progress has been made?Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma.Significant cytostatic effect of everolimus on a gefitinib-resistant anaplastic thyroid cancer cell line harboring PI3KCA gene mutation.Anaplastic Transformation of Papillary Thyroid Carcinoma Only Seen in Pleural Metastasis: A Case Report with Review of the LiteratureEstablishment, characterization and comparison of seven authentic anaplastic thyroid cancer cell lines retaining clinical features of the original tumors.Anaplastic thyroid cancer: Prognostic factors, patterns of care, and overall survival.Significant Amelioration of Tracheal Stenosis following Lenvatinib in a Patient Who Has Anaplastic Thyroid Carcinoma with Bronchomediastinal Infiltration: A Case Report.Nestin expression as an independent indicator of poor prognosis for patients with anaplastic thyroid cancer.Chemosensitivity of anaplastic thyroid cancer based on a histoculture drug response assay.Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.Anaplastic Thyroid Cancer in Sicily: The Role of Environmental Characteristics.Influence of risk grouping on therapeutic decisions in patients with anaplastic thyroid carcinoma.Super-radical surgery for anaplastic thyroid carcinoma: a large cohort study using the Anaplastic Thyroid Carcinoma Research Consortium of Japan database.EZH2 Overexpression as a Useful Prognostic Marker for Aggressive Behaviour in Thyroid Cancer.Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance.Anaplastic thyroid carcinoma: Failure of conventional therapy but hope of targeted therapy.Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Anaplastic Thyroid Carcinoma.Special types of thyroid carcinoma.
P2860
Q28080836-8A441B15-92BF-441E-8B39-0E41F0F6F770Q33571926-EE41F319-DEF8-4254-921F-127EE81490AFQ33849864-2906E847-CB8E-4987-8687-F0ECA9AB7AF7Q33931434-F9CF167C-AABF-4AAE-90BB-FDC4F72E98EAQ34946913-7BB695CE-D469-48F5-BD35-574B70BF6094Q35041578-F822E399-D3FC-4836-94E6-CB676972A2BFQ35137049-AF1AE26F-C64E-40DC-BF7A-F415AD5E44E8Q35144074-2890F73B-F2F9-4B93-9192-AC78B0668B70Q35146510-36823705-219A-43F2-8727-2BF57C32DE3EQ35234108-4FAC80EB-2D93-40A5-890F-71B274119860Q35669034-C4B21B61-B8BE-434C-A69F-90D9D7252D66Q35872419-CE86E901-2724-4E4A-919E-27517A8DF920Q36168031-4F3E4EB0-3DA7-45CF-89DE-E11A9A5F9251Q37179204-505FDD04-0076-41C4-82D4-28FF6D08DC7EQ37199459-A1378D65-BAC9-4F4D-9C02-1E1BC64108AEQ37400472-51C6F2FF-7A1E-46BD-808F-DDDDFE2EB284Q37588162-A3AB3C2C-C59D-4F7C-9045-DFB60B330909Q37644914-2C0E9E9D-09F4-4B48-8AA8-6D7782D0557FQ38072936-A14D9C80-4304-4A77-B7EC-7FB014E973AEQ38080420-6949E1C9-CE2E-4C22-A61F-E4EB53AD5076Q38102673-E9C98801-3F7F-464C-A79C-9320698EFC49Q38189700-37ED2C23-D361-4075-BEBB-130C7B037558Q38217116-053C0E75-EBD5-438E-848F-A55593C548EBQ38798863-B6E87F89-2A3E-4957-B6E1-8818763E2021Q38857266-4932D773-716D-4FAE-A24D-903A694CEAFDQ38934425-6EEB9E69-802A-495A-BACC-14757740039EQ39041602-FF72C427-0086-4237-9CAF-519CF783F2A4Q39984567-F596DF56-CB61-4F42-B518-EDFBF8F0CAB6Q41954414-EE0A3603-1B28-4711-A92B-7538179A0148Q42364077-C50893D0-DFCC-4DC0-875C-315887BE3A9CQ42654525-BF469C9A-00B4-4D09-A02F-D69E1C88FEC7Q42680715-17DFAA43-1C33-4BC9-AD4F-3C850366F145Q43528150-634A8BDF-9676-45AB-BEA7-C8E38AE610B1Q44918252-FDE5E7B8-1601-4B4F-8C6C-1CE5643C0BA9Q45005011-604B5AE0-BFC0-440A-B480-0F88577E7566Q47257495-5640E392-92EF-4C6A-824C-CEE7F679AAFEQ47295202-AA529DA4-C6FC-4368-8263-5FF875D972EFQ47631967-BAFB24E5-CBE8-4A36-9DF5-79777A7A11FCQ47923729-2EF47D03-5B6B-4757-998F-55ECF9D07CD0Q48120106-5F7A89BF-484F-4BDE-8DBD-546E693A1288
P2860
Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Prognostic factors and treatme ...... cohort study of 677 patients.
@en
Prognostic factors and treatme ...... cohort study of 677 patients.
@nl
type
label
Prognostic factors and treatme ...... cohort study of 677 patients.
@en
Prognostic factors and treatme ...... cohort study of 677 patients.
@nl
prefLabel
Prognostic factors and treatme ...... cohort study of 677 patients.
@en
Prognostic factors and treatme ...... cohort study of 677 patients.
@nl
P2093
P1476
Prognostic factors and treatme ...... cohort study of 677 patients.
@en
P2093
Akira Yoshida
Iwao Sugitani
Kiminori Sugino
Shinichi Suzuki
Takahiro Okamoto
P2888
P304
P356
10.1007/S00268-012-1437-Z
P577
2012-06-01T00:00:00Z